ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Solasia enters new license alliance with Maruho biospectrumasia
December 12, 2019Japan based Solasia Pharma K.K. has announced that it has entered into an exclusive license agreement with Maruho Co., Ltd. for the commercialization of Solasia’s product SP-04 (PledOx?), a therapeutic agent for chemotherapy induced peripheral neuropathy
Pharma Sources Insight January 2025
